Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens used for women with early stage breast cancer, according to research from The University of Texas MD Anderson Cancer Center. “By characterizing subsets of patients at greatest risk for developing …

READ FULL ARTICLE Curated publisher From News Medical